These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24070494)

  • 1. Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD.
    Haque R; Hakim A; Moodley T; Torrego A; Essilfie-Quaye S; Jazrawi E; Johnson M; Barnes PJ; Adcock IM; Usmani OS
    J Allergy Clin Immunol; 2013 Nov; 132(5):1166-73. PubMed ID: 24070494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.
    Usmani OS; Ito K; Maneechotesuwan K; Ito M; Johnson M; Barnes PJ; Adcock IM
    Am J Respir Crit Care Med; 2005 Sep; 172(6):704-12. PubMed ID: 15860753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke.
    Mortaz E; Rad MV; Johnson M; Raats D; Nijkamp FP; Folkerts G
    J Mol Med (Berl); 2008 Sep; 86(9):1045-56. PubMed ID: 18600309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients.
    Essilfie-Quaye S; Ito K; Ito M; Kharitonov SA; Barnes PJ
    Respir Med; 2011 Dec; 105(12):1784-9. PubMed ID: 21903370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.
    Kew KM; Dias S; Cates CJ
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
    Sousa AR; Riley JH; Church A; Zhu CQ; Punekar YS; Fahy WA
    NPJ Prim Care Respir Med; 2016 Jun; 26():16031. PubMed ID: 27334739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
    Sin DD; Johnson M; Gan WQ; Man SF
    Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study.
    Moretz C; Sharpsten L; Bengtson LG; Koep E; Le L; Tong J; Stanford RH; Hahn B; Ray R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1721-1737. PubMed ID: 31534326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device.
    Dekhuijzen PNR; Batsiou M; Bjermer L; Bosnic-Anticevich S; Chrystyn H; Papi A; Rodríguez-Roisin R; Fletcher M; Wood L; Cifra A; Soriano JB; Price DB
    Respir Med; 2016 Nov; 120():54-63. PubMed ID: 27817816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Adachi M; Goldfrad C; Jacques L; Nishimura Y
    Respir Med; 2016 Nov; 120():78-86. PubMed ID: 27817819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy.
    Hakim A; Usmani OS
    Ther Deliv; 2015; 6(4):443-51. PubMed ID: 25996043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Inhaled Corticosteroid/Long-Acting β
    Leitao Filho FS; Takiguchi H; Akata K; Ra SW; Moon JY; Kim HK; Cho Y; Yamasaki K; Milne S; Yang J; Yang CWT; Li X; Nislow C; van Eeden SF; Shaipanich T; Lam S; Leung JM; Sin DD
    Am J Respir Crit Care Med; 2021 Nov; 204(10):1143-1152. PubMed ID: 34464242
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination.
    Kilaru SC; Bansal AG; Naik VS; Lopez M; Gogtay JA
    Expert Rev Respir Med; 2022 May; 16(5):529-540. PubMed ID: 35727177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.